Revising You the Staging for Pancreatic Cancer in 2012
DOI:
https://doi.org/10.6092/1590-8577/717Keywords:
Blood Vessels, General Surgery, Neoplasm Staging, Pancreas, Pancreatic NeoplasmsAbstract
No abstract available.Downloads
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
Surveillance Epidemiology and End Results (SEER). U.S. Cancer Statistics: 1999-2007 Incidence and Mortality Report. Available at http://www.seer.cancer.gov/publications/uscs.html (Accessed January 31, 2012)
Saif MW. Controversies in the adjuvant treatment of pancreatic adenocarcinoma. JOP. J Pancreas (Online) 2007; 8:545-52.
Kim R, Saif MW. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? JOP. J Pancreas (Online) 2007; 8:279-88.
Saif MW. Is there a standard of care for the management of advanced pancreatic cancer? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008. JOP. J Pancreas (Online) 2008; 9:91-8
Exocrine and endocrine pancreas. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 241-9.
Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996; 12:373-80.
National Comprehensive Cancer Network, Inc (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Pancreatic Adenocarcinoma Version 2.2012. Fort Washington, PA, USA: National Comprehensive Cancer Network, Inc (NCCN), 2012. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
Pimiento JM, Hutchinson T, Weber JM, Patel MR, Hodul PJ, Chuong MD, et al. Multimodality therapy for borderline resectable pancreatic cancer: A single-institution experience. J Clin Oncol 30, 2012 (suppl 4; abstr 280)
Chakraborty S, Bauer TW, Morris MM, Yarde E, Parsons JT, Adams RB, Sanoff HK. Accelerated fraction radiotherapy with concomitant capecitabine as neoadjuvant therapy of borderline resectable pancreatic cancer. J Clin Oncol 30, 2012 (suppl 4; abstr 329)
Papavasiliou P, Piposar JR, Arrangoiz R, Chen KT, Zhu F, Chun YS, Hoffman JP. Margin status and neoadjuvant chemoradiation in patients with borderline resectable pancreatic cancer. J Clin Oncol 30, 2012 (suppl 4; abstr 304)
Ashman JB, Moss AA, Callister MD, Reddy KS, Mulligan DC, Gunderson LL, Borad MJ. Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma. J Clin Oncol 30, 2012 (suppl 4; Abstr 327)
